Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Branislav, Stančák"'
Autor:
Roy S. Gardner, Pramodsingh Thakur, Eric F. Hammill, Devi G. Nair, Zayd Eldadah, Branislav Stančák, Kevin Ferrick, Charn Sriratanasathavorn, Gábor Zoltán Duray, Ramesh Wariar, Yi Zhang, Qi An, Viktoria Averina, John P. Boehmer
Publikováno v:
ESC Heart Failure, Vol 8, Iss 2, Pp 1571-1581 (2021)
Abstract Aims This study aims to characterize the range of implantable device‐based sensor values including heart sounds, markers of ventilation, thoracic impedance, activity, and heart rate for patients with heart failure (HF) when patients were d
Externí odkaz:
https://doaj.org/article/01b474194f5e45b286cb654754a1ab3f
Publikováno v:
Bratislavske lekarske listy. 122(2)
Objectives and background Studies assessing the unicentric and prospective comparison of efficacy of cryoballoon pulmonary vein isolation in idiopathic and non-idiopathic atrial fibrillation (AF) patients are missing. The aim of this study was to com
Autor:
Marek Hudák, Branislav Stančák, Erika Komanová, Jan Kyselovic, Michal Kerekanič, Silvia Mišíková, Alexander Bohó
Publikováno v:
Acta cardiologica. 73(2)
Cardiac troponin I (cTnI) is a valuable prognostic biomarker in patients with chronic heart failure (CHF). However, the prognostic importance of cTnI in patients who received cardiac resynchronisation therapy (CRT) remains unknown. The aim of this pr
Autor:
Peter Spurný, Michal Kerekanič, Alexander Bohó, Silvia Mišíková, Erika Komanová, Marek Hudák, Branislav Stančák
Publikováno v:
Wiener klinische Wochenschrift. 127:779-785
Atrial fibrillation is the most prevalent cardiac arrhythmia with significant healthcare impact with regards to treatment costs, morbidity, and mortality. Many of the focal electrical activities that initiate and sustain atrial fibrillation have been
Autor:
Erika Komanová, Marek Hudák, Branislav Stančák, Silvia Mišíková, Alexander Bohó, Michal Kerekanič
Publikováno v:
Acta cardiologica. 72(2)
Objectives Prolongation of QRS (≥ 120 ms) in patients with heart failure (HF) is associated with higher all-cause mortality than in those with narrow QRS. The aim of our study was to compare the survival of patients with HF and wide QRS after cardi
Autor:
Marek Hudák, Michal Kerekanič, Branislav Stančák, Peter Spurný, Silvia Mišíková, Alexander Bohó, Adriana Sudzinová, Erika Komanová
Publikováno v:
International Journal of Cardiology. 171:217-223
Background Cryoballoon ablation technique for the treatment of atrial fibrillation (AF) is a complex procedure consisting of several procedural steps associated with significant risk of complications. The aim of this single-centre study was to give d
Autor:
Adrián Kolesár, Peter Mitro, Vincent Nagy, Marta Jakubová, František Sabol, Branislav Stančák, Paul Cisarik
Publikováno v:
Interactive CardioVascular and Thoracic Surgery. 15:1007-1012
OBJECTIVES: Atrial fibrillation is the most common arrhythmia after cardiac surgery. The pathogenesis of postoperative atrial fibrillation is multifactorial. The aim of the study was to analyse preoperative, intraoperative and postoperative factors a
Autor:
Adrián Kolesár, Marta Jakubová, František Sabol, Ján Luczy, Branislav Stančák, Jana Jevčáková, Ingrid Schusterova, Martin Beňa, Jaroslav Špatenka
Publikováno v:
Cor et Vasa. 53:649-653
Jednou z možných komplikacii po implantacii chlopňových nahrad je vznik protetickej endokarditidy. Ide o život ohrozujucu komplikaciu, ktora si vyžaduje komplexnu a narocnu liecbu. Jednou z liecebných alternativ je použitie alogenneho kryopre
Publikováno v:
Wiener klinische Wochenschrift. 119:428-434
OBJECTIVE: Oxidative stress plays an important role in the pathogenesis of chronic obstructive pulmonary disease (COPD). Oxidant/antioxidant imbalance has also been reported in various forms of pulmonary hypertension. The present study aimed to asses
Publikováno v:
Wiener klinische Wochenschrift. 117:210-214
OBJECTIVE: The insertion (I)/deletion (D) polymorphism of the angiotensin-converting enzyme (ACE) gene has been associated with an increased risk of cardiovascular diseases. In patients with primary pulmonary hypertension, the homozygous ACE DD genot